This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Massachusetts Institute of Technology. Active years: 2005-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2011
Title: Yosuf El-Shabrawi: Innovator in Heparinase Research
Introduction
Yosuf El-Shabrawi is a prominent inventor based in Graz, Austria. He has made significant contributions to the field of biochemistry, particularly in the study of heparinase III and its applications. With a total of 4 patents, his work has the potential to impact various medical treatments and research methodologies.
Latest Patents
El-Shabrawi's latest patents focus on modified forms of heparinase III. These inventions include methods for sequencing heparin-like glycosaminoglycans (HLGAGs) and applications in cancer treatment. The modified heparinase III exhibits reduced enzymatic activity, making it useful for various purposes, such as removing active heparan sulfate from solutions and inhibiting angiogenesis. His inventions also explore methods for treating cancer and inhibiting tumor cell growth and metastasis through the use of heparinase III.
Career Highlights
Yosuf El-Shabrawi is affiliated with the Massachusetts Institute of Technology, where he conducts his research. His innovative work has garnered attention in the scientific community, contributing to advancements in biochemistry and therapeutic applications.
Collaborations
El-Shabrawi has collaborated with notable colleagues, including Dongfang Liu and Kevin Pojasek. These partnerships have further enriched his research and expanded the scope of his inventions.
Conclusion
Yosuf El-Shabrawi is a distinguished inventor whose work on heparinase III has the potential to revolutionize treatments for cancer and other medical conditions. His contributions to the field of biochemistry are noteworthy and continue to inspire further research and innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile